Inovio Pharmaceuticals, Inc.
INOBiotechnology
$0.60−21.95%As of Oct 30vs prior close
- Market cap
- $62.3M
- P/E (TTM)
- –
- From 52W high
- −76.83%
- EPS (YE25)
- -$1.81
- Revenue (YE25)
- $65.3K
- Net margin
- -130000.00%
Nomior Score
12
Distressed LaggardBottom 3% of the scored universe
Growth—
Quality12
Value36
Momentum27
Resilience20
Growth
−50.31%revenue a year over 9 fiscal years
YE16 $35.4MYE25 $65.3K
Connections
Revenue to profitQ1 YE25
The operating loss was 38337% of revenue.
Who owns it
1fund